Publication | Closed Access

A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia

Hematological MalignancyProgression-free SurvivalChronic Myeloid LeukaemiaMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaMalignant Blood DisorderPopulation StudyCell BiologyAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchHealth Sciences